期刊文献+

Caveolin-3基因多态性的筛查及其在中国汉族糖尿病患者中的特点 被引量:2

Screening for Caveolin-3 gene polymorphism in Chinese Han diabetic patients
下载PDF
导出
摘要 目的:观察我国汉族正常人和2型糖尿病(T2DM)患者Caveolin-3(CAV3)基因的多态性差异,并介绍一种研究CAV3相关遗传病的实用方法。方法:CAV3基因只有2个很短的外显子,使用PCR-SSCP进行筛查,然后选择性测序。针对性地设计引物,经过PCR-SSCP分别测定50例正常人和50例T2DM样本的基因外显子基因多态性情况。结果:PCR-SSCP发现T2DM患者CAV3基因电泳变异累计发生率为48%,而正常人变异累计发生率为7%,存在显著差异(P<0.001)。抽查变异条带,测序证实发生了碱基变异。结论:中国人T2DM的CAV3基因存在增加的多态性特征,PCR-SSCP法可有效地进行初步筛查;提示CAV3基因多态性可能是中国人T2DM发生的遗传背景之一。 Objective To observe the difference of caveolin-3 (CAV3) gene polymorphism between normal people and diabetic patients in Chinese Han population. Methods Exon gene polymorphism in 50 normal people and 50 T2DM patients were detected by PCR-SSCP. Results The cumulative incidence rate of electrophoretic variation in T2DM patients was 48%, while cumulative incidence rate of normal people was 7% (P 〈 0.001 ). It was proved that in the variant bands, there were base variant. Conclusions The variant base number of CAV3 gene in human T2DM samples are significantly more than the normal which can be preliminary detected by PCR-SSCP. It indicates that CAV3 gene polymorphism may be one of the genetic backgrounds for the occurence of Chinese T2DM.
出处 《实用医学杂志》 CAS 北大核心 2014年第11期1757-1759,共3页 The Journal of Practical Medicine
基金 国家自然科学基金项目(编号:NO.81160102) 广西医学科学实验中心开放实验室项目(编号:NO.2402209039)
关键词 糖尿病 2型 Caveolin-3 基因多态性 PCR-SSCP Diabetes mellitus, type 2 Caveolin-3 Gene polymorphism PCR-SSCP
  • 相关文献

参考文献2

二级参考文献31

  • 1Doyle DD, Ambler SK, Upshaw-Earley J, et al. Type B atrial natriuretic peptide receptor in cardiac myocyte caveolae [ J ]. Circ Res,1997,81 ( 1 ) :86-91.
  • 2Au CG, Cooper ST, Lo HP, et al. Expression of aquap-orinm 1 in human cardiac and skeletal muscle[ J]. J Mol Cell Cardiol, 2004,6(5) :655-662.
  • 3Ueda H, Oikawa A, Nakamura A, et al. Neuregulin receptor ErbB2 localization at T-tubule in cardiac and skeletal muscle [ J ].Cytochem, 2005,53( 1 ) :87-91.
  • 4Oka N, Asai K, Kudej RK, et al. Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice [ J ]. Am J Physiol, 1997,273(6 Pt 1 ) :C1957-1962.
  • 5De Luca A, Sargiacomo M, Puca A. Characterization of cveolae from rat heart: localization of postreceptor signal transduction molecules and their rearrangement after norepinephrine stimulation [ J ]. J Cell Biochem, 2000,77(4) :529-539.
  • 6Yarbrough TL, Lu T, Lee HC, et al. Localization of cardiac sodium channels in caveolin-rich membrane domains : regulation of sodium current amplitude[J]. Circ Res, 2002,90(4) :443-449.
  • 7Garcia-Cardena G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the nos caveolin bining domain in vivo[ J]. J Biol Chem, 1997,272(41 ) :25437-25440.
  • 8Wang X, Abdel-Rahman AA. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts[ J].Am J Physiol Heart Circ Physiol, 2002,282 ( 6 ): H2309-H2315.
  • 9Ohsawa Y, Toko H, Katsura M, et al. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitgric oxide synthase activity[J]. Hum Mol Genet, 2004,13(2) :151-157.
  • 10Damy T, Ratajczak P, Shah AM, et al. Increased neuronal nitgric oxide synthase-derived NO production in the failing human heart[ J].Lancet, 2004,363(9418) :1365-1367.

共引文献19

同被引文献29

  • 1黄勤,王庭槐.心肌细胞caveolin-3的相关信号转导[J].国际病理科学与临床杂志,2005,25(4):297-299. 被引量:7
  • 2Marx J. Caveolin-3 helps build muscles [ J ]. Science, 2001,294 (5548) :1864.
  • 3Murfitt L, Whiteley G, Iqbal MM, et al. Targeting caveolin-3 for the treatment of diabetic cardiomyopathy [ J ]. Pharmacol Ther, 2015,151:50-71.
  • 4Sotgia F, Woodman SE, Bonuccelli G, et al. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease [ J ]. Am J Physiol Cell Physiol, 2003,285 ( 5 ) : C1150-1160.
  • 5Weiss N, Couchoux H, Legrand C, et al. Expression of the mus- cular dystrophy-associated caveolin-3 (P104L) mutant in adult mouse skeletal muscle specifically alters the Ca (2 + ) channel function of the dihydropyridine receptor [ J ]. Pflugers Arch, 2008, 457(2) :361-375.
  • 6Couchoux H, Allard B, Legrand C, et al. Loss of caveolin-3 in- duced by the dystrophy-associated PIO4L mutation impairs L-type calcium channel function in mouse skeletal muscle cells [ J ]. J Physiol, 2007,580( Pt. 3 ) :745-754.
  • 7Ohsawa Y, Hagiwara H, Nakatani M, et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition[ J]. J Clin Invest, 2006,116 ( 11 ) :2924-2934.
  • 8Ohsawa Y, Toko H, Katsura M, et al. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity[J]. Hum Mol Genet, 2004,13(2) : 151-157.
  • 9Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue- specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo[ J]. J Biol Chem, 1997,272(46) :29337-29346.
  • 10Parton RG, Way M, Zorzi N, et al. Caveolin-3 associates with de- veloping T-tubules during muscle differentiation[J]. J Cell Biol, 1997,136 ( 1 ) : 137-154.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部